Cell MedX Corp. (CMXC)
OTHER OTC:CMXC
US Market
Holding CMXC?
Track your performance easily

Cell MedX (CMXC) Financial Statements

19 Followers

Cell MedX Financial Overview

Cell MedX's market cap is currently ―. The company's EPS TTM is $-0.002; its P/E ratio is -16.67; Cell MedX is scheduled to report earnings on August 30, 2021, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 24Nov 23Aug 23May 23Feb 23
Income Statement-
Total Revenue---$ 74.00$ 222.00
Gross Profit--$ -30.00K$ 2.29K$ 711.00
EBIT$ 106.54K$ -78.70K$ -111.04K$ -1.24M$ -198.85K
EBITDA$ 106.54K$ -78.70K$ -111.04K$ -1.24M$ -198.85K
Net Income Common Stockholders$ 119.97K$ -157.24K$ -213.89K$ -1.34M$ -329.34K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 79.68K$ 22.62K$ 58.07K$ 98.30K$ 7.63K
Total Assets$ 81.92K$ 22.88K$ 62.33K$ 103.27K$ 13.90K
Total Debt$ 0.00$ 52.75K$ 168.80K$ 165.61K$ 143.98K
Net Debt$ -79.68K$ 30.12K$ 110.73K$ 67.31K$ 136.35K
Total Liabilities$ 791.86K$ 2.55M$ 2.53M$ 2.49M$ 2.32M
Stockholders Equity$ -784.95K$ -2.53M$ -2.47M$ -2.39M$ -2.30M
Cash Flow-
Free Cash Flow$ -37.95K$ -35.33K$ -66.26K$ -40.23K$ -136.14K
Operating Cash Flow$ -37.95K$ -35.33K$ -66.26K$ -40.23K$ -136.14K
Investing Cash Flow-----
Financing Cash Flow$ 95.00K-$ 25.90K$ 130.99K$ 125.39K
Currency in USD

Cell MedX Earnings and Revenue History

Cell MedX Debt to Assets

Cell MedX Cash Flow

Cell MedX Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis